These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 693386)

  • 1. [Effect of hydrochlorothiazide on calcium-magnesium parameters in patients with recurrent nephrolithiasis].
    Musialik D; Głuszek J; Raszeja-Wanic B
    Pol Tyg Lek; 1978 Jul; 33(30):1173-5. PubMed ID: 693386
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of oral calcium loading on the serum magnesium concentration and its urinary excretion in patients with recurrent calcium nephrolithiasis and hypercalciuria--differential diagnostic potentials].
    Ivanov I; Tsachev K
    Vutr Boles; 1989; 28(1):65-70. PubMed ID: 2741443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interrelationship between calcium and magnesium homeostasis and its significance for the relapse-prevention treatment of calcium nephrolithiasis].
    Tsachev K; Ivanov I
    Vutr Boles; 1990; 29(4):48-52. PubMed ID: 2281659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium, phosphorus and magnesium metabolism in patients with recurrent nephrolithiasis].
    Kwias Z; Twardosz W
    Pol Przegl Chir; 1976; 48(5):605-10. PubMed ID: 1272989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hydrochlorothiazide on selected parameters of calcium and magnesium metabolism in immobilized patients].
    Pupek-Musialik D; Raszeja-Wanic B; Rajewski F
    Pol Tyg Lek; 1978 Aug; 33(34):1333-6. PubMed ID: 704435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D; Głuszek J; Pieczyńska A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):739-42. PubMed ID: 1669148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide.
    Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():125-34. PubMed ID: 6937988
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER; Cohanim M
    Clin Invest Med; 1986; 9(1):44-50. PubMed ID: 3955921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary magnesium excretion in nephrolithiasis].
    Simeonov S; Dimitrakova D; Kumchev E
    Vutr Boles; 1988; 27(6):39-43. PubMed ID: 3247702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria].
    Ivanov I; Tsachev K
    Vutr Boles; 1990; 29(3):64-8. PubMed ID: 2284802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What has been achieved in the therapy of calcium nephrolithiasis?].
    Tschöpe W; Ritz E
    Internist (Berl); 1979 Dec; 20(12):599-606. PubMed ID: 398355
    [No Abstract]   [Full Text] [Related]  

  • 12. The myth of long-term thiazide-induced magnesium deficiency.
    Cohen L; Kitzes R; Shnaider H
    Magnesium; 1985; 4(4):176-81. PubMed ID: 4079463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of urolithiasis and nephrocalcinosis in hypomagnesemia.
    Revúsová V; Zvara V; Karlíková L; Suchánek B
    Czech Med; 1985; 8(4):207-13. PubMed ID: 3937709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium homeostasis in mild-to-moderate primary hyperparathyroidism.
    Johansson G; Danielson BG; Ljunghall S
    Acta Chir Scand; 1980; 146(2):85-91. PubMed ID: 7415750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium metabolism in renal stone disease.
    Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of prostaglandin inhibition on the antihypercalciuric action of hydrochlorothiazide: a plausible hypothesis].
    Calò L
    Medicina (Firenze); 1988; 8(4):432-4. PubMed ID: 3244301
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrolithiasis in a neonate with transient renal wasting of calcium and magnesium.
    Stoll ML; Listman JA
    Pediatr Nephrol; 2002 May; 17(5):386-9. PubMed ID: 12042901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral content in idiopathic calcium nephrolithiasis.
    Barkin J; Wilson DR; Manuel MA; Bayley A; Murray T; Harrison J
    Miner Electrolyte Metab; 1985; 11(1):19-24. PubMed ID: 3974535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.